Otsuka Progresses Digital Push With US Approval Of MDD App

First Such Adjunctive Therapy

Otsuka/Click’s global-first adjunctive digital therapy for depression marks another step by pharmaceutical firms going digital for psychotherapy through collaborations.

The global first approval for the digital adjunctive therapeutic for MDD can further expand Otsuka's digital portfolio.
global-first approval for digital adjunct therapy for MDD set to expand Otsuka's digital health portfolio • Source: Shutterstock

More from New Products

More from Scrip